Prospective, Randomized, Crossover Trial Comparing Recombinant von Willebrand Factor (rVWF) vs. Tranexamic Acid (TA) to Minimize Menorrhagia in Women with Type 1 von Willebrand Disease: The VWD Minimize Study

April 25, 2019
https://clinicaltrials.gov/ct2/show/NCT02606045
Hematology Non Malignant
Principal Investigator: Philip Kuriakose, MD

 

 Von Willebrand Factor, Tranexamic Acid, Von Willebrand Disease

Accepting Participants